Vaxcell Bio Therapeutics banner

Dividends

Vaxcell Bio Therapeutics
does not pay dividends

Shareholder Yield

Current shareholder yield for Vaxcell Bio Therapeutics is .

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Vaxcell Bio Therapeutics

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Vaxcell Bio Therapeutics

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

Price
Vaxcell Bio Therapeutics

Annual Price Range
4 835
52w Low
3 585
52w High
11 000
Price Metrics
Average Annual Return -32.99%
Standard Deviation of Annual Returns 20.82%
Max Drawdown -96%
Shares Statistics
Market Capitalization 112B KRW
Shares Outstanding 23 260 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

Stock Splits

Vaxcell Bio Therapeutics's latest stock split occurred on Nov 10, 2023

The company executed a 6-for-5 stock split, meaning that for every 5 shares held, investors received 6 new shares.

Before the split, Vaxcell Bio Therapeutics traded at 23999.9908 per share. Afterward, the share price was about 21250.

The adjusted shares began trading on Nov 10, 2023. This was stock split number 3 in Vaxcell Bio Therapeutics's history, following the previous one in Sep 20, 2023.

Pre-Split Price
19 999.9924 23 999.9908
Post-Split Price
21 250
Before
After